EMA — authorised 1 August 2018
- Marketing authorisation holder: Roche Registration GmbH
- Status: approved
🇪🇺 Ocrevus in European Union
EMA authorised Ocrevus on 1 August 2018
Marketing authorisation
Ocrevus in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Neuroscience approved in European Union
Frequently asked questions
Is Ocrevus approved in European Union?
Yes. EMA authorised it on 1 August 2018.
Who is the marketing authorisation holder for Ocrevus in European Union?
Roche Registration GmbH holds the EU marketing authorisation.